These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 9590570)

  • 21. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
    Messerli FH; Soria F
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():557-63. PubMed ID: 7841089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk reduction following regression of cardiac hypertrophy.
    Schmieder RE
    Clin Exp Hypertens A; 1990; 12(5):903-16. PubMed ID: 2145097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The heart and vascular changes in hypertension.
    Leonetti G; Cuspidi C
    J Hypertens Suppl; 1995 Aug; 13(2):S29-34. PubMed ID: 8576785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for exercise and screening for safe athletic participation in hypertensive youth.
    Baker-Smith CM; Pietris N; Jinadu L
    Pediatr Nephrol; 2020 May; 35(5):743-752. PubMed ID: 31025109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension: reflections on risks and prognostication.
    Kannel WB
    Med Clin North Am; 2009 May; 93(3):541-58, Table of Contents. PubMed ID: 19427490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HARVEST: looking for optimal management of young people with stage 1 hypertension.
    Palatini P
    Panminerva Med; 2021 Dec; 63(4):436-450. PubMed ID: 33709681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
    Laufer E; Reid C; Qi XL; Jennings GL
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Contemporary Approach to Hypertensive Cardiomyopathy: Reversing Left Ventricular Hypertrophy.
    Bourdillon MT; Vasan RS
    Curr Hypertens Rep; 2020 Sep; 22(10):85. PubMed ID: 32889649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural cardiovascular alterations and blood pressure variability in human hypertension.
    Mancia G; Giannattasio C; Turrini D; Grassi G; Omboni S
    J Hypertens Suppl; 1995 Aug; 13(2):S7-14. PubMed ID: 8576791
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.